Study of the therapeutic effect of Doripenem in an acute appendicitis patient

Study of the therapeutic effect of Doripenem in an acute appendicitis patient - The effect of Doripenem in an acute appendicitis patient

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008256

Enrollment

Registered

2012-07-01

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute appendicitis

Interventions

Doripenem is administered once as intravenous drip infusion with 0.5 g 3 times per day to a patient with localized peritonitis. Doripenem is administered once as intravenous drip infusion with 1 g 3

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient with the acute appendicitis which chose the medical treatment by an antibiotic

Exclusion criteria

Exclusion criteria: The patient who has a medical treatment history by an antibiotic to acute appendicitis. The patient who is experienced in allergy to doripenem. The patient who is treated with valproate sodium. A patient with renal dysfunction (less than [ Ccr 50ml ]).

Design outcomes

Primary

Measure	Time frame
The effective patients' percentage	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026